Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of IRS1 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of IRS1 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of IRS1 mRNA | decreases expression | 20458559
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of IRS1 mRNA | affects expression | 20382639
|
C511635 |
bis(allixinato)oxovanadium(IV) |
bis(allixinato)oxovanadium(IV) results in increased phosphorylation of IRS1 protein | increases phosphorylation | 17805585
|
C512927 |
bis(alpha-furancarboxylato)oxovanadium(IV) |
bis(alpha-furancarboxylato)oxovanadium(IV) inhibits the reaction [Dexamethasone results in decreased expression of IRS1 mRNA] | decreases expression|decreases reaction | 18812026
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of IRS1 mRNA | increases expression | 16029874
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of IRS1 mRNA | affects expression | 17484886
|
D002330 |
Carmustine |
Carmustine results in decreased expression of IRS1 mRNA | decreases expression | 15980968
|
D002791 |
Cholesterol, Dietary |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of and results in decreased phosphorylation of IRS1 protein | affects cotreatment|decreases expression|decreases phosphorylation | 19509184
|
C503589 |
cis-9, trans-11-conjugated linoleic acid |
cis-9, trans-11-conjugated linoleic acid inhibits the reaction [TNF protein results in decreased expression of IRS1 mRNA] | decreases expression|decreases reaction | 17327424
|
D003513 |
Cycloheximide |
[Cycloheximide co-treated with Estradiol] results in increased expression of IRS1 mRNA | affects cotreatment|increases expression | 15072547
|
D003513 |
Cycloheximide |
Cycloheximide results in decreased expression of IRS1 mRNA | decreases expression | 15072547
|
D003520 |
Cyclophosphamide |
[Doxorubicin co-treated with Cyclophosphamide] affects the expression of IRS1 mRNA | affects cotreatment|affects expression | 16322899
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of IRS1 mRNA | decreases expression | 20106945
|
D003907 |
Dexamethasone |
bis(alpha-furancarboxylato)oxovanadium(IV) inhibits the reaction [Dexamethasone results in decreased expression of IRS1 mRNA] | decreases expression|decreases reaction | 18812026
|
D003907 |
Dexamethasone |
Dexamethasone results in decreased expression of IRS1 mRNA | decreases expression | 18812026
|
D004041 |
Dietary Fats |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of and results in decreased phosphorylation of IRS1 protein | affects cotreatment|decreases expression|decreases phosphorylation | 19509184
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine affects the expression of IRS1 mRNA | affects expression | 20387270
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of IRS1 mRNA | increases expression | 16002434
|
D004317 |
Doxorubicin |
[Doxorubicin co-treated with Cyclophosphamide] affects the expression of IRS1 mRNA | affects cotreatment|affects expression | 16322899
|
D004958 |
Estradiol |
[Cycloheximide co-treated with Estradiol] results in increased expression of IRS1 mRNA | affects cotreatment|increases expression | 15072547
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of IRS1 mRNA | affects cotreatment|decreases expression | 15688983
|
D004958 |
Estradiol |
Estradiol promotes the reaction [AKT1 protein modified form binds to IRS1 protein] | affects binding|increases reaction | 19435893
|
D004958 |
Estradiol |
Estradiol results in decreased phosphorylation of IRS1 protein | decreases phosphorylation | 15949379
|
D004958 |
Estradiol |
Estradiol results in increased expression of IRS1 mRNA | increases expression | 15072547 16029874 15688983
|
D004958 |
Estradiol |
NVP-AEW541 inhibits the reaction [Estradiol promotes the reaction [AKT1 protein modified form binds to IRS1 protein]] | affects binding|decreases reaction|increases reaction | 19435893
|
D004958 |
Estradiol |
PTEN protein affects the reaction [Estradiol promotes the reaction [AKT1 protein modified form binds to IRS1 protein]] | affects binding|affects reaction|increases reaction | 19435893
|
D004958 |
Estradiol |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of IRS1 mRNA] | decreases reaction|increases expression | 15688983
|
D004958 |
Estradiol |
Estradiol results in increased phosphorylation of IRS1 protein | increases phosphorylation | 15604210
|
D000431 |
Ethanol |
Ethanol affects the phosphorylation of IRS1 protein | affects phosphorylation | 18377926
|
D005227 |
Fatty Acids |
Fatty Acids affects the expression of IRS1 mRNA | affects expression | 17940560
|
D005576 |
Forskolin |
Forskolin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IRS1 mRNA] | decreases reaction|increases expression | 17407152
|
D005632 |
Fructose |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of and results in decreased phosphorylation of IRS1 protein | affects cotreatment|decreases expression|decreases phosphorylation | 19509184
|
D005632 |
Fructose |
Fructose results in decreased expression of IRS1 mRNA | decreases expression | 19165636
|
D005632 |
Fructose |
Fructose results in decreased expression of IRS1 protein | decreases expression | 19008412
|
D005632 |
Fructose |
NOS3 protein inhibits the reaction [Fructose results in decreased expression of IRS1 protein] | decreases expression|decreases reaction | 19008412
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of IRS1 mRNA | decreases expression | 15072547
|
D006581 |
Hexachlorobenzene |
Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in increased phosphorylation of IRS1 protein] | decreases reaction|increases phosphorylation | 16237195
|
D006581 |
Hexachlorobenzene |
Hexachlorobenzene results in increased expression of IRS1 protein | increases expression | 16237195
|
D006581 |
Hexachlorobenzene |
Hexachlorobenzene results in increased phosphorylation of IRS1 protein | increases phosphorylation | 16237195
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in increased expression of IRS1 mRNA | increases expression | 15072547
|
C533894 |
LG 100815 |
LG 100815 results in decreased expression of IRS1 mRNA | decreases expression | 16951191
|
D008770 |
Methylnitrosourea |
Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in increased phosphorylation of IRS1 protein] | decreases reaction|increases phosphorylation | 16237195
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased phosphorylation of IRS1 protein | increases phosphorylation | 16237195
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IRS1 mRNA] | decreases reaction|increases expression | 17407152
|
C002741 |
N-nitrosomorpholine |
N-nitrosomorpholine results in increased expression of IRS1 protein | increases expression | 9466558
|
C501177 |
NVP-AEW541 |
NVP-AEW541 inhibits the reaction [Estradiol promotes the reaction [AKT1 protein modified form binds to IRS1 protein]] | affects binding|decreases reaction|increases reaction | 19435893
|
C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in decreased expression of IRS1 mRNA | decreases expression | 16951191
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of IRS1 mRNA | decreases expression | 18445702
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of IRS1 mRNA | increases expression | 18301758
|
D011374 |
Progesterone |
Progesterone results in decreased phosphorylation of IRS1 protein | decreases phosphorylation | 15949379
|
D011374 |
Progesterone |
Progesterone results in increased phosphorylation of IRS1 protein | increases phosphorylation | 15604210
|
C059514 |
resveratrol |
resveratrol results in decreased activity of [IRS1 protein binds to PIK3R1 protein] | affects binding|decreases activity | 17550345
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [INS1 protein promotes the reaction [IRS1 protein binds to PIK3R1 protein]] | affects binding|decreases reaction|increases reaction | 16626303
|
D017673 |
Sodium Chloride, Dietary |
Sodium Chloride, Dietary results in increased phosphorylation of IRS1 protein | increases phosphorylation | 14670806
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of IRS1 mRNA | affects expression | 14699072
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of IRS1 mRNA | affects cotreatment|decreases expression | 15688983
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of IRS1 mRNA] | decreases reaction|increases expression | 15688983
|
D013749 |
Tetrachlorodibenzodioxin |
AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of IRS1 mRNA] | affects reaction|decreases expression | 20181658
|
D013749 |
Tetrachlorodibenzodioxin |
Forskolin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IRS1 mRNA] | decreases reaction|increases expression | 17407152
|
D013749 |
Tetrachlorodibenzodioxin |
MAPK8 protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of IRS1 protein] | affects reaction|decreases expression | 20181658
|
D013749 |
Tetrachlorodibenzodioxin |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IRS1 mRNA] | decreases reaction|increases expression | 17407152
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of IRS1 mRNA | decreases expression | 18691609 20181658
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of IRS1 protein | decreases expression | 20181658
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of IRS1 mRNA | increases expression | 17407152
|
D013749 |
Tetrachlorodibenzodioxin |
TNF protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of IRS1 protein] | affects reaction|decreases expression | 20181658
|
D013749 |
Tetrachlorodibenzodioxin |
TNFRSF1A protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of IRS1 protein] | affects reaction|decreases expression | 20181658
|
D013749 |
Tetrachlorodibenzodioxin |
U 0126 inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of IRS1 protein] | decreases expression|decreases reaction | 20181658
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of IRS1 protein] | decreases expression|decreases reaction | 20181658
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.12 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
7.09 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.09 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.08 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.08 | 11192467 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
5.07 | 17694057 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.48 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.73 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.22 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.22 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.22 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
9.22 | 15113128 15688392 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.04 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.04 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
14.85 | 17620307 17162532 19052882 16434500 19061943 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
14.85 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
14.85 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.15 | 21441931 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.89 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
Cholesterol, Dietary |
4.53 | 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.53 | 16183991 16162502 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.59 | 11748828 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.41 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.67 | 11141031 |
MESH:D001161 |
Arteriosclerosis |
|
Cholesterol, Dietary |
14.99 | 15552841 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
14.99 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
14.99 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
6.80 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.80 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.02 | 16873680 17967414 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.45 | 11514358 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
13.11 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
13.11 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.11 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.36 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.49 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.27 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.49 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.91 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.85 | 15665606 15380490 15845082 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.87 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
7.93 | 16187019 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
7.93 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
11.90 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
11.90 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
11.90 | 16978400 11325840 17020986 18234424 15093573 17388661 12006526 18323546 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
11.90 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
11.90 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
11.90 | 15136595 15994142 15939500 16322301 15634643 16595493 18695136 16935488 16264153 15692762 18628466 17369602 16096432 15567936 19526202 16826403 18234424 17983394 11325840 15993339 15668708 17426702 18382427 16115903 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
11.90 | 17289903 19861407 12948864 18497071 14630087 16675129 17018787 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
11.90 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Hexachlorobenzene |
11.90 | 15061365 12709520 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
11.90 | 11306469 16253758 14633655 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
11.90 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
11.90 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
11.90 | 16818667 19155303 19059307 18629630 16873071 18815881 19410462 20544844 18425577 18351453 18821012 15565566 17242785 15668708 19289846 19189210 17261762 19084267 19244106 19189212 17440819 11161223 21152245 19011961 20859285 20135344 19487384 17893378 19142967 19221464 16273361 19115204 20065188 16202921 19103187 18855134 20005174 18984771 19200415 19288272 20390343 18997820 19066611 17049068 21138602 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
11.90 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.94 | 11589617 |
MESH:D002056 |
Burns |
|
Ethanol |
4.24 | 16374292 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.04 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.37 | 16050911 16227642 3786805 15673190 10355542 15721981 16011737 15700767 16097048 16192424 18705752 16124888 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.38 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.47 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.10 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
24.21 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
24.21 | 15073043 16217749 15553829 11135700 14691202 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
24.21 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
24.21 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
24.21 | 19701751 19519916 18785209 20524982 19052882 19394651 3084413 20084675 16878318 20935162 16807293 17428255 16569478 19383236 19171122 19107877 16935385 18665156 16328049 10737359 10672840 3581430 19919837 19418558 18506893 19335982 20514400 20512989 17173139 18971187 17055752 21159647 16288022 16779866 18210153 11831363 17978847 16698587 20214788 16540662 17761372 20432363 19539802 18494052 18393292 20007298 19208518 18056438 16502159 16681979 18788625 18691550 20727157 16830150 17138121 17162532 20101231 18978308 19822196 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
24.21 | 18059187 16234567 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
24.21 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
24.21 | 15289165 15763234 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
N-nitrosomorpholine |
24.21 | 16935385 1701930 15543204 11509945 15010824 2885971 9029167 19383236 1917145 19335982 1967229 10629087 8364915 9311599 9466558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
24.21 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
24.21 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.57 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
10.09 | 16152834 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
10.09 | 16675471 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.45 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
9.92 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
9.92 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
N-nitrosomorpholine |
9.92 | 1429202 7921415 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.75 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
6.87 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
6.87 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
6.87 | 16227395 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.25 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
6.05 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.05 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.25 | 17308081 16364871 16952015 16109756 16278810 15505089 17924179 16651473 16242529 17329180 17007740 17131338 15811867 18627295 16455267 16731534 17382496 17351982 16612575 17519947 17974986 16269455 15792986 15476868 17928571 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.79 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.18 | 15458977 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
3.74 | 12484553 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
18.01 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
18.01 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
18.01 | 17174075 21159647 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
18.01 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
18.01 | 7505956 2727394 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.15 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.15 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.72 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.72 | 19176532 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.36 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
5.32 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.32 | 15668235 8697196 16354765 15340226 12621046 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.72 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
3.71 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.71 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.25 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.25 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.25 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.71 | 17141729 14669216 |
MESH:D003324 |
Coronary Artery Disease |
marker/mechanism |
|
| |
MESH:D003327 |
Coronary Disease |
|
Fructose |
7.87 | 18504504 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
7.87 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.79 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
4.98 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
4.98 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
4.98 | 11873399 19302082 15513904 15451039 10194807 11198716 15451040 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.98 | 15322242 10048152 20055451 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.61 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.56 | 18710439 12388444 18483878 16413132 12161096 18093676 17979934 10498854 17010015 16614059 18295254 15276878 16651033 18372110 10700343 18433785 16989017 15643279 11948286 12913760 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.71 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.95 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.02 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.22 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
bis(alpha-furancarboxylato)oxovanadium(IV) |
17.23 | 17651728 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
17.23 | 15331540 11751995 10990075 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
17.23 | 18603373 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
17.23 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.08 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
marker/mechanism |
|
| 19734900 15688983 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.52 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
6.52 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.52 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
12.99 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
12.99 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
12.99 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.08 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.31 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
13.42 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
13.42 | 6623471 16227642 7120509 7440962 19336974 10915739 15027814 21278145 3786805 9327722 7179309 4309450 2869522 17522070 11566570 16177239 10092053 15968718 3732212 19085960 15998439 6884620 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
13.42 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
13.42 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
13.42 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
13.42 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.08 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.08 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.15 | 18367378 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.06 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
13.41 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
13.41 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
13.41 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
13.41 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.47 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
18.70 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
18.70 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
18.70 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
18.70 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
10.86 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
10.86 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
10.86 | 17893378 19155303 20544844 16202921 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.73 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.73 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.73 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.44 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.81 | 11006010 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.69 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.58 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
6.58 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
6.58 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.70 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
42.49 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
42.49 | 12631006 17595544 12795759 16239168 15959796 61145 16045604 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
42.49 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
42.49 | 17967931 19004024 18296743 19551842 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
42.49 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
42.49 | 16409862 19236843 18620774 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
42.49 | 19196556 18641190 18395287 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
42.49 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
42.49 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.24 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.98 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.88 | 16946407 10194807 15513904 15451040 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.05 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.11 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
10.05 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.05 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
4.81 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
23.41 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
23.41 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
23.41 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Fructose |
23.41 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
23.41 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.86 | 16904648 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.27 | 15046732 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.80 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
6.66 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
6.66 | 17150277 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
3.39 | 9825942 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.09 | 11389073 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
4.94 | 19165636 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.17 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.63 | 16376943 15172196 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.24 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.10 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.19 | 16330681 16495754 18674790 16244372 16144979 17875725 12587719 14766674 16244371 16879835 17888722 18006777 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.17 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.17 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.53 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.00 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.88 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.96 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.11 | 14986274 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.20 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.91 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.91 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.91 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.60 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.76 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
6.56 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.56 | 18501091 15147373 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.33 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.62 | 15340226 16354765 8697196 16959395 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.39 | 18783367 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.11 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol, Dietary |
13.37 | 10876104 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
13.37 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
13.37 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.82 | 20558911 |
MESH:D006946 |
Hyperinsulinism |
marker/mechanism |
|
| 19734900 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.55 | 18563319 14757778 15752949 19008412 18360027 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
13.36 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
13.36 | 15752949 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
13.36 | 16873680 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
14.59 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
14.59 | 17042910 |
MESH:D006973 |
Hypertension |
|
Fructose |
14.59 | 14568997 14573337 14633139 16843071 19008412 |
MESH:D006973 |
Hypertension |
|
Sodium Chloride, Dietary |
14.59 | 18524855 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
14.59 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.68 | 15338365 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.71 | 19799862 19342510 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.94 | 17488730 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.90 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
10.12 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
10.12 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
9.92 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
9.92 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
9.92 | 7193160 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
20.74 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
20.74 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
20.74 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
20.74 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
20.74 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
20.74 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
20.74 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.12 | 16624496 |
MESH:D007333 |
Insulin Resistance |
marker/mechanism |
|
| 19734900 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
20.25 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
20.25 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
20.25 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
20.25 | 14633139 19008412 18563319 17133782 14573337 19799862 18981581 19342510 18057795 14757778 19586609 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
20.25 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
8.87 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.87 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.01 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
8.64 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
8.64 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
8.64 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.78 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
14.96 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
14.96 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
14.96 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
14.96 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.80 | 15451040 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
5.88 | 15070760 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
5.88 | 10602166 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.73 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.31 | 17658394 17802794 17296974 17008537 18587576 18172266 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.42 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
10.36 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
10.36 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
7.58 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
7.58 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.39 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.06 | 16467208 17050201 20471514 19850784 16968895 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
6.86 | 17712046 11161223 17107899 17217047 9834237 15336539 19035177 16330433 19642359 12018890 16891316 19225113 16823087 12679006 16966277 17869043 15213294 15622746 16112521 15748426 17649720 16331271 11468182 12712474 19075265 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
6.86 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.95 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.55 | 11830472 10052129 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
7.64 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
7.64 | 15526292 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.86 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
13.80 | 17157831 16221502 17174718 16943688 11903743 11408273 21278145 16239168 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
13.80 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
13.80 | 20032147 19638242 18522880 18407596 18665156 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
13.80 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.68 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
14.43 | 15818738 12632512 15730626 17976157 12898905 12609069 17761835 18395095 17698563 18418968 17922224 20821823 18251166 12667390 15931870 17525996 18472094 15123356 17557913 17640975 14748882 12445421 16015684 18420326 17481882 15876570 12389079 11481614 12445418 16027843 17805973 12958196 18210741 12741479 18006644 18376398 15673190 15362042 12666154 18429990 15370692 18166357 17714472 15996030 18472332 12586293 15338365 17766677 16248980 18481824 18054572 15959796 18277467 18263696 17823541 14716833 16638106 17900296 12649538 18156304 18412020 16097048 12546737 15057751 17869086 18705752 12632514 17721639 14716496 16033810 17708605 10355542 14620537 18279442 18395914 18187930 15925388 16192424 14512876 18339082 16136751 13678700 17565644 17631135 15893842 14724832 15650968 18205269 15052691 16011737 16116963 17944888 18317297 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
cis-9, trans-11-conjugated linoleic acid |
14.43 | 17869086 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
14.43 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
14.43 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
14.43 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
14.43 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
14.43 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
14.43 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
14.43 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.67 | 16964402 17285989 15830285 16246199 15720792 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.67 | 17034775 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.24 | 17207112 17347304 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.75 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.33 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
19.23 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
19.23 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
19.23 | 21071580 19294768 20434301 18977376 19850985 18648771 19551842 19426721 19255062 20101389 19090486 19690152 2862719 19254457 19427195 10737359 21047994 12771043 19642983 19638242 19073162 18754104 21167192 18644402 16942905 15175105 15885732 20452335 2422723 21278145 19996281 19812893 20501860 19499222 20583210 12112319 19833225 20137499 18978307 20405173 20118626 20492335 9163691 19256749 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
19.23 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
19.23 | 19812893 19321006 20405173 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
19.23 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
19.23 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
19.90 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
19.90 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
19.90 | 21159647 18775883 17174075 16267830 9362446 19539802 17854601 19009564 2563599 18079962 3124819 18544905 18282651 18164116 18308698 17942915 16842330 18253720 19004024 18093689 19126423 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
19.90 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Hexachlorobenzene |
19.90 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
19.90 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.03 | 15213294 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
5.05 | 16080182 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
9.74 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
9.74 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
9.74 | 6695378 20970405 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
9.74 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
9.74 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
9.74 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
9.74 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
11.02 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
11.02 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
11.02 | 11418001 16257854 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
15.07 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
15.07 | 14633661 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
15.07 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
12.67 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
12.67 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
12.67 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.16 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
8.61 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
8.61 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
20.02 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
20.02 | 11807958 17203775 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
20.02 | 17020996 14999141 14633655 12931682 10838139 16944150 17131329 15688392 16051031 11807958 16827153 10767621 19196723 15313902 16619500 11751437 15113128 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
20.02 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
20.02 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
20.02 | 14580682 16827153 11731420 19196722 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.22 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.22 | 19453300 |
MESH:D008545 |
Melanoma |
|
Carmustine |
6.63 | 12393984 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
6.63 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
6.63 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
6.63 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.76 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.39 | 16388313 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.79 | 15451040 18411066 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.88 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.00 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
4.47 | 19165636 18497449 17261469 17098227 16815490 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.36 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.12 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.37 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
10.46 | 19549372 19417148 14977855 11468182 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
10.46 | 15744524 15867202 16118317 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
10.46 | 14749477 17049120 17164350 16490592 16267019 17935668 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.45 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.10 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.24 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.74 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
6.74 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
8.42 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.42 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
8.42 | 16525036 16317513 17188708 16456233 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.91 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.91 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.18 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.18 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.34 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.44 | 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.56 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.47 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.47 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
8.47 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.37 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
7.18 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
7.18 | 15533788 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.18 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
8.17 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.17 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.57 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.32 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.36 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.01 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.13 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.13 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
14.06 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.06 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.06 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
2.84 | 10525206 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
5.07 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
6.46 | 8761367 15176712 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.46 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.40 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.40 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.47 | 8761367 12837982 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.01 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.69 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
3.94 | 8291058 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
6.82 | 21332399 18674790 17217161 11836018 19632207 16723640 18457598 20518802 20132043 |
MESH:D009765 |
Obesity |
|
Fructose |
6.82 | 18585860 17707055 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
6.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.07 | 12819281 16049721 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.29 | 16517039 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.87 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.78 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.57 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
10.12 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.12 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
10.12 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
10.12 | 16211241 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.30 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
14.58 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
14.58 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
14.58 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
14.58 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
14.58 | 16965848 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.78 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Cholesterol, Dietary |
4.01 | 19014385 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.82 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.73 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.73 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Hexachlorobenzene |
9.78 | 9918132 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
9.78 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
marker/mechanism |
|
| 9466558 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.78 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
7.78 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
7.01 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
7.01 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
13.87 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
13.87 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
13.87 | 11399792 11896295 11118676 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.36 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.31 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.31 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 15678496 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.78 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.78 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.78 | 16289102 12479363 15754350 16644109 18247401 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.78 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.78 | 15897917 16868541 18437689 16888761 15749863 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.78 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
2.78 | 12376480 15682402 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.78 | 16731767 17636462 17718901 17804756 15767336 17675339 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.78 | 15067354 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.07 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.37 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.11 | 16636934 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.81 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.16 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.85 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.85 | 17058453 16314181 17520802 15827377 16317513 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
3.63 | 11700416 18379247 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
4.10 | 18172121 18155124 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
5.07 | 11555667 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.70 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.63 | 15625365 18313854 16767912 15675481 17203757 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
8.96 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
8.96 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.37 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.44 | 16636934 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.15 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
5.15 | 9754883 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
8.30 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
8.30 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.30 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.16 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.87 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.09 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
9.48 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
9.48 | 19457130 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.90 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
4.38 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.38 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
4.38 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
4.38 | 16257854 15930296 18593901 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
6.33 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
6.33 | 9211565 11906479 9562338 16755016 17189318 17918041 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.12 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.57 | 16684133 16045194 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.89 | 9754883 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.64 | 12837982 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
4.81 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.47 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
14.55 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
14.55 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
14.55 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
14.55 | 7505956 3078959 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.26 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.85 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.54 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
13.92 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
13.92 | 11780464 20435036 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
13.92 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
13.92 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
13.92 | 16712894 8653321 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
3.90 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
3.74 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.58 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.74 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
10.35 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
10.35 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.17 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
8.98 | 17334414 16364871 17678736 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
8.98 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.82 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.39 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.01 | 17120751 |